Department of Analytical Chemistry, Faculty of Sciences, University of Córdoba, Edificio Anexo Marie Curie, Campus de Rabanales, 14071 Córdoba, Spain.
J Chromatogr A. 2010 Feb 26;1217(9):1447-54. doi: 10.1016/j.chroma.2009.12.073. Epub 2010 Jan 4.
Supramolecular solvents are here proposed firstly as extractants in solid sample microextractions. The approach was evaluated by extracting flumequine (FLU) and oxolinic acid (OXO), two widely used veterinary medicines, from fish and shellfish muscle using a supramolecular solvent made up of decanoic acid (DeA) reverse micelles. The antibiotics were extracted in a single step (approximately 15 min), at room temperature, using 400 microL of solvent. After centrifugation, an aliquot of the extract was directly analyzed by liquid chromatography and fluorescence, without the need of clean-up or solvent evaporation. Contrary to the previously reported methods, both OXO and FLU were quantitatively extracted from fish and shellfish, independently of sample composition. The high extraction efficiencies observed for these antibiotics were a consequence of their amphiphilic character which resulted in the formation of DeA-OXO and DeA-FLU mixed aggregates. The quality parameters of this quantitative method including sensitivity, linearity, selectivity, repeatability, trueness, ruggedness, stability, decision limit and detection capability were evaluated according to the 2002/657/EC Commission Decision. Quantitation limits in the different samples analyzed (salmon, sea trout, sea bass, gilt-head bream, megrim and prawns) ranged between 6.5 and 22 microg kg(-1) for OXO and, 5 and 15 microg kg(-1) for FLU. These limits were far below the current maximum residue limits (MRLs) set by the European Union (EU) (i.e. 100 and 600 microg kg(-1), for OXO and FLU, respectively). The trueness of the method was determined by analyzing a Certified Reference Material (CMR, BCR-725) consisting of a lyophilised salmon tissue material. Recoveries for fortified samples (50-100 microg kg(-1) of OXO and 50-600 microg kg(-1) of FLU) and their relative standard deviations were in the intervals 99-102% and 0.2-5%, respectively. The repeatability, expressed as relative standard deviation, was 3.6% for OXO and 2.3% for FLU ([OXO]=[FLU]=200 microg kg(-1) and n=11).
超分子溶剂首次被提议用作固相微萃取中的萃取剂。该方法通过使用癸酸(DeA)反胶束制备的超分子溶剂从鱼类和贝类肌肉中提取两种广泛使用的兽药 flumequine(FLU)和 oxolinic acid(OXO)来评估。抗生素在室温下一步(约 15 分钟)提取,使用 400 μL 溶剂。离心后,直接对提取液的一部分进行液相色谱和荧光分析,无需净化或溶剂蒸发。与之前报道的方法相反,OXO 和 FLU 均可从鱼类和贝类中定量提取,而与样品组成无关。这些抗生素的高萃取效率是由于它们的两亲性,导致形成 DeA-OXO 和 DeA-FLU 混合聚集体。根据 2002/657/EC 委员会决定,对该定量方法的质量参数(灵敏度、线性、选择性、重复性、准确度、精密度、稳定性、决策限和检测能力)进行了评估。在不同分析样品(鲑鱼、海鳟、鲈鱼、金头鲷、鲷鱼和对虾)中,OXO 的定量限为 6.5-22μgkg(-1),FLU 的定量限为 5-15μgkg(-1)。这些限量远低于欧盟(EU)设定的当前最大残留限量(MRL)(即 OXO 为 100μgkg(-1),FLU 为 600μgkg(-1))。通过分析由冻干鲑鱼组织材料组成的认证参考材料(CMR,BCR-725)来确定该方法的准确度。对于加标样品(50-100μgkg(-1)的 OXO 和 50-600μgkg(-1)的 FLU),回收率及其相对标准偏差分别在 99-102%和 0.2-5%之间。重复性表示为相对标准偏差,对于 OXO 为 3.6%,对于 FLU 为 2.3%([OXO]=[FLU]=200μgkg(-1),n=11)。